Two-year experience with FK 506 in pediatric patients.

This publication has 10 references indexed in Scilit:

• The clinical trial of FK 506 as primary and rescue immunosuppression in pediatric cardiac transplantation.
  1991
• FK 506 versus cyclosporine in pediatric liver transplantation.
  1991
• FK 506 rescue in chronic graft-versus-host-disease after bone marrow transplantation.
  1991
• FK 506 conversion of renal allografts failing cyclosporine immunosuppression.
  1991
• FK 506 in the management of transplant-related nephrotic syndrome and steroid-resistant nephrotic syndrome.
  1991
• Pediatric renal transplantation under FK 506 immunosuppression.
  1991
• FK 506-associated diabetes mellitus in the pediatric transplant population is a rare complication.
  1991
• Posttransplant lymphoproliferative disorders occurring under primary FK 506 immunosuppression.
  1991
• Use of FK 506 in pediatric patients.
  1991
• Pancreatic islet transplantation after upper abdominal exeriteration and liver replacement
  The Lancet, 1990